The Street’s missing the playbook while chasing sneaker ghosts. KG’s acquisition will slam revenue 500bps above expectations as the fashion pendulum swings violently toward dresses. Yet the stock ...

Imexpharm Pharmaceutical JSC (IMP) has reported a strong profit rebound in the second quarter of 2025, driven mainly by a ...